Poland· PL-100059987
Sandostatin
A octreotide product containing octreotidum, registered in Poland by Novartis Poland Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Octreotide is registered in 17 of 19 countries.
Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Octreotide · ATC H01CB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of octreotide costs, country by country.
Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Octreotide · price per daily dose (0.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$41.46
The record
At a glance
URPL (Poland)- Active substance
- Octreotidum
- Manufacturer
- Novartis Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- H01CB02
- ATC class
- Octreotide
- Defined daily dose
- 0.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin059099900427155 amp.po 1 mlPLN 39.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for octreotide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Octreotide · interactions on record
367 records
- 4 severe
- 151 moderate
- 4 minor
- 168 info
Most severe, free to view
- LonafarnibA16AX20severe
- PexidartinibL01EX15severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Octreotide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOctreotide AcetateMylan Institutional LLC
- IrelandOctreotide 50 micrograms/1 ml solution for injectionPfizer Healthcare Ireland Unlimited Company
- SpainSANDOSTATIN 50 microgramos/ml SOLUCION INYECTABLE Y PARA PERFUSIONNovartis Farmaceutica S.A.
- NorwaySandostatinNovartis Norge (2)
- SwedenSandostatin 50 mikrogram/ml Injektions-/infusionsvätska, lösningNovartis Sverige AB
- United KingdomOctreotide 100micrograms/1ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- BelgiumMycapssa 20 mgAmryt Pharmaceuticals DAC
- CzechiaOCTREOTIDE TEVATeva B.V., Haarlem
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Octreotide Ratiopharm, Sandostatin
- Belgium · Octreoteva Long Acting, Octreotide Qilu
- Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
- Cyprus · Octreotide Rompharm, Sandostatin
- Czechia · Octreotide Teva, Octreotide Teva B.V.
- Germany · Octreo Ratiopharm, Octreotid Bendalis
- Denmark · Octreoanne, Octreotid Sun
- Estonia · Octreotide Teva, Sandostatin
- Spain · Octreotida Gp-Pharm, Octreotida Sun
- Finland · Octreotide Orion, Octreotide Ratiopharm
- France · Octreotide Arrow, Octreotide Hospira
- United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
- Greece · Okrodin, Sandostatin
- Croatia · Oktreotid Teva, Sandostatin
- Hungary · Oktreotid Teva, Sandostatin
- Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
- Iceland · Octreoanne, Oczyesa
- Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
- Liechtenstein · Oczyesa
- Lithuania · Octreotide Teva, Sandostatin
- Luxembourg · Octreoteva Long Acting, Sandostatine
- Latvia · Sandostatin, Sandostatin Lar
- Malta · Sandostatin, Sandostatin Lar
- Netherlands · Octreotide Bendalis, Octreotide Depot Teva
- Norway · Octreoanne, Octreotide Orion
- Portugal · Octreotido Color, Octreotido Depot Teva
- Romania · Octreotidă Rompharm, Octreotidă Teva
- Sweden · Octreotide Orion, Octreotide Teva
- Slovenia · Oktreotid Teva, Sandostatin
- Slovakia · Sandostatin, Sandostatin Lar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/606233ff-c368-40ec-ac21-efd6de060b72 GET /v1/drugs/606233ff-c368-40ec-ac21-efd6de060b72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań / do infuzji",
"source": "urpl",
"strength": "50 mcg/ml",
"packaging": "05909990042715 ¦ Rp ¦ 58908\n5 amp. 1 ml",
"substance": "Octreotidi acetas 0.05 mg",
"common_name": "Octreotidum",
"pl_product_id": "100059987",
"pozwolenie_nr": "00427",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about octreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.